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Abstract
Background: There is a dearth of studies exploring the magnitude of mental disorders amongst
adolescents and youths in the Arab world. To our knowledge, this phase 2 survey in Oman is the
first nationally representative school-based study to determine the prevalence of DSM-IV mental
disorders (lifetime and over the preceding 12 months), their age-of-onset distributions and
determine their severity over the past 12 months using the World Mental Health-Composite
International Diagnostic Interview, the WMH-CIDI, used for international comparison.
Methods: A total of 1,682 (91.61%) students out of 1836 students who formed the phase 2
random sub-sample of a multi-stage, stratified, random sampling design (phase 1), participated in
the face-to-face structured interview using the Arabic-version of WMH-CIDI 3.0.
Results:  The phase 1 results using the General Health Questionnaire (GHQ-12) and Child
Depression Inventory (CDI) showed depressive symptoms to be 17% prevalent in the larger
sample of 5409 adolescents and youths. Amongst the phase 2 respondents from this sample, 13.9%
had at least one DSM IV diagnostic label. The lifetime prevalence of Major Depressive Disorder
(MDD) was 3.0%; Bipolar Mood Disorder (BMD) was 1%, Specific phobia 5.8% and Social phobia
1.6%. The female gender was a strong predictor of a lifetime risk of MDD (OR 3.3, 95% CI 1.7-6.3,
p = 0.000); Any Mood Disorders (OR 2.5, 95% CI 1.4-4.3, p = 0.002) and Specific Phobia (OR 1.5,
95% CI 1.0-2.4, p = 0.047). The severity of illness for cases diagnosed with 12 month DSM IV
disorders was found to be 80% lower in females (OR 0.2, 95%CI 0.0-0.8). The estimates over the
previous 12 month period when compared with the lifetime prevalence showed a 25% to 40%
lower prevalence for MDD, Specific phobia, Social phobia, Any Anxiety Disorders (AAD) and Any
Mood disorders (AMD) while the rate was 80% lower for Separation Anxiety Disorder/Adult
Separation Anxiety (SAD/ASA). Mood disorders were significantly lower in the 14-16 age groups
(70% lower) in comparison to the older age groups and AMD showed a linear increase in
prevalence across increasing age groups (p = 0.035).
Conclusion:  The implications of the present findings are not clear cut, however this study
endorses the adult CIDI studies findings that mental disorders do begin earlier in life. The relatively
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lower prevalence of DSM IV depressive disorders cautions against any conclusive interpretation of
the inflated results based on the exclusive study of the depressive symptoms alone in the same
sample in the same time period. The female gender proved to be a strong predictor of lifetime risk
of MDD, any mood disorder and specific phobia. Under-reporting by males or some other gender-
specific factors may have contributed to such a discrepancy. The odds of the severity of illness for
cases with 12 month DSM IV disorders were significantly lower in females.
Background
Mental disorders, though difficult to conceptualize and
measure, tend to contribute significantly to disability and
mortality as well as an exacerbation of other medical con-
ditions and vice versa [1]. The progress in descriptive epi-
demiology of Child and Adolescent Mental Disorders
(CAMDs) has been hampered by a more severe version of
the same measurement difficulties that plague adult stud-
ies [2]. The version 3.0 of the World Mental Health - Com-
posite International Diagnostic Interview (WMH-CIDI) of
the World Health Organization (WHO) [3] has been doc-
umented to yield reliable and valid diagnoses of mental
disorders based on Diagnostic and Statistical Manual of
Mental Disorders, 4th edition (DSM-IV) [4] and Interna-
tional Classification of Diseases, (ICD-10) [5] criteria. The
use of CIDI in epidemiological and cross-cultural surveys
[2] has revealed that mental disorders are among the most
prevalent classes of chronic diseases in the general adult
population, with lifetime-to-date prevalence often close
to 50% of the population and with 12-month prevalence
typically in the 12% to 25% range. In contrast to the adult
findings, the estimates of the prevalence, severity and
unmet need for treatment of CAMDs are imprecise. This
suggests the lack of importance given to the study of
CAMDs [6]. Current estimates indicate that as many as 7%
to 22% of all children and adolescents are affected [7] and
up to 50% of all adult mental disorders have their onset
in adolescence [8]. Results from adult CIDI surveys con-
sistently show that anxiety disorders have a median age of
onset in the early to late teens, while mood disorders have
a median age of onset in the early to mid twenties [2].
Oman has a population of approximately 3.5 million,
with 42.7% of its inhabitants being under the age of 15.
The median age of the total population is 18.8 years, it
being 21.1 years for males and 16.7 years for females [9].
In 2005, more than one quarter (27.82%) of the Omani
population was between 15 and 24 years of age [10]. In a
nationally representative study in 2005, 17% of Omani
secondary school students were found to suffer from sub-
clinical depressive symptoms [11]. These symptoms are
often assumed to translate into clinical depressive illness
and its co-morbidities. These findings needed to be cor-
roborated in the light of the fact that this secondary school
age is a critical developmental stage in the life of an indi-
vidual and carries various ramifications for the health and
well-being of the individual, social cohesion, and the eco-
nomic prosperity of a nation. The present study using the
WMH-CIDI, aimed to determine the prevalence of DSM-
IV mental disorders (lifetime and 12 month), their age-of-
onset distributions and their severity (in the past 12
months cases) among the Omani adolescents and youths
studying in the secondary schools.
Methodology
Samples and diagnostic assessment
This study was the second phase of the two-stage epidemi-
ological survey conducted in 2005. The respondents in
both study phases were between 14 and 23 years of age
[11]. The survey adopted a nationally representative,
multi-stage, stratified random sampling design to select its
subjects. The latest data obtained from the Ministry of
Education, Oman was used as the sampling frame [12].
The sample was weighted (Table 1) based on the number
of Omani secondary school students from all the different
regions of Oman, their gender distribution, their classes
ranging from grade 1 to grade 3 and their stream of study
[13].
In the first phase (phase 1), a screening of 2,739 male and
2,670 female adolescents and youths (total n = 5,409)
with the General Health Questionnaire (GHQ-12) and
the 27 item Child Depression Inventory (CDI) was con-
ducted.
The second phase (phase 2), which is reported here, stud-
ied a random sub-sample of 1,836 respondents from the
above sample of which 1,682 (91.61%) agreed to partici-
pate in the face-to-face structured interview using the Ara-
bic version of WMH-CIDI, PAPI (Paper and Pencil
Instrument) version 3.0 [14]. This version was not vali-
dated but was professionally translated into Arabic based
on a five-step process of forward translation, back transla-
tion, resolution of discrepancies between translation and
back translation, pilot testing, and final revision[14].
Training for the school health doctors (interviewers) was
conducted by certified CIDI qualified trainers as described
elsewhere [15]. The Ministry of Education sent circulars to
the sampled secondary schools to ensure their participa-
tion. The purpose of the study, its methodology and the
consent forms supplied by the researchers were appended
with the circular. The respective schools obtained writtenChild and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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consent from the parents of the sampled respondents. It
was clarified that the participation of their child, even
after selection, was not compulsory and the parents had
the choice to refuse enrollment. They were assured of con-
fidentiality of the findings if their child was selected to be
interviewed. Prior to the actual interview, a verbal consent
was obtained from the respondent. The Ethics Committee
of the Omani Ministry of Health approved the study.
The CIDI was administered in two parts. Part 1 included a
DSM IV core diagnostic assessment screen (Part 1 sample
(P1): n = 1,682; males = 832, females = 850). Part 2
included questions about risk factors, consequences, and
other correlates (health service utilization, adequacy of
treatment) along with assessments of additional disorders
that were administered to all Part 1 respondents who met
lifetime criteria for any disorder. This formed the Part 2
(P2) sample consisting of 507 respondents; males = 238,
females = 269.
Terminology
a) Hierarchal diagnosis
A DSM IV diagnosis hierarchy rule has been applied in
this study to assess the lifetime prevalence [16] and 12
month prevalence [17] for Generalized Anxiety Disorder
(GAD), Major Depressive Disorder (MDD), Dysthymia
and Intermittent Explosive Disorder (IED) but not for
other diagnostic labels.
b) Any disorder: Collapsing the rows and columns [18]
Any Mood disorder (AMD) and Any Anxiety disorder
(AAD) were calculated using part 1 weights in this study
(refer tables 2 and 3) while Any Impulse Control disorder
(AICD) was calculated using part 2 weights. These are
aggregated categories of the disorder created by collapsing
the rows and/or columns in the tables for that particular
category when there are too few respondents with individ-
ual disorders in that particular category. AAD includes
Panic disorder, GAD, Social phobia, Agoraphobia without
panic, PTSD, and SAD (Separation Anxiety Disorder)/ASA
(Adult Separation Anxiety).
c) Severity of illness [17]
Only those respondents who met criteria for 12 month
WMH-CIDI DSM IV disorder (table 2) were assessed for
the 12-month severity of their disorder (Table 3). The
methodological details in the WMH-CIDI related to the
severity and impairment issue are available elsewhere
[19]. For this analysis the following criteria defined by the
Department of Health Care Policy, Harvard Medical
School, Boston, USA were used and these are based on
similar criteria used in a template paper [17]. It has been
recommended that these be used in articles for publica-
tions.
Severe: either the respondent is diagnosed with a 12-
month Bipolar I disorder; or the respondent has
attempted suicide in last 12-months and has any 12-
month diagnosis; or if the respondent has more than one
12-month diagnosis and a high level of impairment on
the Sheehan Disability Scale.
Moderate: At least one 12-month disorder and a moderate
level of impairment.
Table 1: Sociodemographic distribution of the study sample compared to population of secondary school Omani students
P1 Unweighted P2 Unweighted P1 Weighted P2 Weighted No. of students*
N % N % N%N% N %
Male 832 49.5 238 47.0 794.6 47.2 239.5 47.2 52167 47.2
Female 850 50.5 269 53.1 887.4 52.8 267.5 52.8 58253 52.8
Grade
Grade 1 675 40.2 174 34.34 679.5 40.4 204.8 40.4 44610 40.4
Grade 2 - Art 270 16.1 79 15.58 234.3 13.9 70.6 13.9 15382 13.9
Grade 2 - Science 293 17.4 97 19.14 297.7 17.7 96.8 19.1 19544 17.7
Grade 3 - Art 216 12.8 68 13.42 214.7 12.8 57.7 11.4 13061 11.8
Grade 3 - Science 228 13.6 89 17.55 255.7 15.2 77.1 15.2 17823 16.1
Region
Muscat 277 16.5 75 14.8 324.6 19.3 97.8 19.3 21306 19.3
Dhofar 197 11.7 71 14.0 153.1 9.1 46.1 9.1 10049 9.1
Al-Dakhliyah 258 15.3 82 16.2 238.6 14.2 71.9 14.2 15666 14.2
N Sharqiyah 134 8.0 52 10.3 117.1 7.0 35.3 7.0 7688 7.0
S Sharqiyah 140 8.3 41 8.1 123.9 7.4 37.3 7.4 8132 7.4
N Batinah 366 21.8 110 21.7 367.4 21.8 110.8 21.8 24121 21.8
S Batinah 193 11.5 42 8.3 223.5 13.3 67.4 13.3 14676 13.3
Al-Dhahirah 117 7.0 34 6.7 133.8 8.0 40.3 8.0 8782 8.0
Total 1682 100.0 507 100.0 1682 100.0 507 100.0 110420 100.0
* Source Ministry of Education data 2002Child and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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Mild: any 12-month disorder.
The high level of impairment was defined on a 0-10 visual
analogue scale as a score of =/>8 on two out of the maxi-
mum four Sheehan Disability Scale [20] domains (home,
school/work, people or social); moderate level as any
domain with score =/> 4 and mild as any domain between
0 and 3.
d) Age of onset of mental disorders (AOO) [21]
AOO of the mental disorders was based on retrospective
reporting. It may be recalled incorrectly. The AOO focuses
on the onset of the syndrome, ignoring any prodrome at
an earlier age.
Statistical analysis
The data was entered in BLAISE software version 6.3.4.6,
cleaned and sent to the Department of Health Care Policy,
Table 2: Prevalence of DSM IV disorders
Total prevalence Age groups
12 month Lifetime 14-16 17-18 19-23 ChiSq+ P&
N%
(SE)
N%
(SE)
%
(SE)
%
(SE)
%
(SE)
Anxiety Disorders
Panic disorder* 2 0.1
(0.1)
20 . 1
(0.1)
0.0
(0.0)
0.2
(0.1)
0.0
(0.0)
2.0 0.368
GAD with hierarchy* 3 0.2
(0.1)
50 . 3
(0.1)
0.4
(0.3)
0.3
(0.2)
0.0
(0.0)
4.8 0.090
Social phobia* 81 4.5
(0.5)
27 1.6
(0.3)
2.1
(0.6)
1.5
(0.4)
1.3
(0.7)
0.8 0.678
Specific phobia* 22 1.3
(0.3)
102 5.8
(0.6)
4.4
(0.9)
7.0
(0.9)
4.5
(1.2)
5.0 0.081
Agoraphobia without panic* 18 1.0
(0.2)
25 1.5
(0.3)
1.4
(0.6)
2.0
(0.5)
0.3
(0.3)
8.8 0.013
PTSD ** 5 0.4
(0.2)
70 . 5
(0.2)
0.0
(0.0)
0.8
(0.4)
0.5
(0.4)
4.7 0.096
SAD/ASA ** 3 0.6
(0.5)
16 3.0
(1.0)
0.2
(0.2)
5.3
(1.8)
0.3
(0.3)
7.3 0.027
Any Anxiety disorder@ 54 5.6
(1.1)
79 9.0
(1.4)
5.9
(1.8)
11.3
(2.2)
7.4
(2.6)
3.5 0.171
Mood disorders
MDD with hierarchy* 37 2.2
(0.4)
49 3.0
(0.4)
2.1
(0.6)
2.9
(0.6)
5.0
(1.5)
3.6 0.170
Dysthymia with hierarchy* 5 0.4
(0.2)
50 . 4
(0.2)
0.2
(0.2)
0.5
(0.3)
0.4
(0.4)
0.9 0.643
Bipolar-broad* nc^ nc 17 1.0
(0.3)
0.5
(0.3)
1.3
(0.4)
1.0
(0.6)
2.5 0.289
Bipolar I/II/Sub threshold* 13 0.9
(0.3)
nc nc nc nc nc nc nc
Any Mood disorder* 53 3.3
(0.5)
69 4.3
(0.5)
2.6
(0.7)
4.6
(0.8)
6.4
(1.6)
6.7 0.035
Impulse control disorders
Conduct disorder** 2 0.2
(0.1)
20 . 2
(0.1)
0.1
(0.1)
0.1
(0.1)
0.8
(0.8)
1.8 0.406
ADHD** 3 0.1
(0.1)
40 . 2
(0.1)
0.0
(0.0)
0.2
(0.1)
0.3
(0.3)
3.7 0.162
IED with hierarchy* 24 1.5
(0.3)
31 1.9
(0.3)
2.5
(0.7)
1.5
(0.4)
2.0
(0.9)
1.5 0.472
Any Impulse control disorder** 21 3.1
(1.0)
25 3.5
(1.0)
5.9
(2.8)
2.0 (0.8) 4.4
(2.1)
2.7 0.263
*Part 1 sample, prevalence calculated using part 1 weights.
**Part 2 sample, prevalence calculated using part 2 weights.
@12 month prevalence (Part 1 weights); lifetime prevalence (Part 2 weights)
& P value is for lifetime prevalence
+ Degree of freedom is 2
^ nc = not calculatedChild and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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Harvard Medical School, Boston, USA for the analysis.
The analysis was done by the Statistical Analysis Software
(SAS) program and was based on the same statistical
methodology used in the previously reported CIDI studies
[[16-18,21], and [22]]. The sample distribution was com-
pared with the national data [12] on gender, region,
school grades and stream of study (science or arts) varia-
bles. The phase 1 stratification (by gender, region and
grade) was done by proportional allocation and the
number of classes needed was calculated for each gender,
region and grade which resulted in an equal probability
sample. Hence there was no need to make an adjustment
for a "phase 1" weight (the school selection weight). The
data were weighted to adjust for differential non-response
and inclusion in the Part 2 sample. The post-stratification
weights were calculated for region, by sex and by grade
(details available on request). The weights were applied to
all subjects in this phase two study being reported (n =
1682). There was no adjustment made for within school
probability of selection, since a third of subjects within
each class were selected. Prevalence and standard error of
lifetime and 12 month DSM IV disorders and that within
the age cohort (age at interview) are reported here as per-
centages. Lifetime prevalence was estimated as the propor-
tion of respondents who were already having a given
disorder up to their age at interview. Age of onset and pro-
jected lifetime risk as of age 75 years were estimated using
the two-part actuarial method implemented in SAS ver-
sion 8.2. The distributions of cumulative lifetime risk esti-
mates for the disorders were standardized and examined
for fixed percentiles based on the age of onset distribu-
tions (Table 4). The three age cohorts used in analysis
were 14-16 years, 17-18 years and 19-23 years. Sociode-
mographic predictors (gender and age cohort) were exam-
ined using discrete-time survival analysis with person-
years as the unit of analysis. Standard errors of prevalence
estimates and survival coefficients were estimated using
the Taylor series linearization method implemented in
the SUDAAN software system. Multivariate significance
tests were made with Wald Chi-squared tests using Taylor
series design-based coefficient variance-covariance matri-
ces. Standard errors of lifetime risk estimates were esti-
mated using the jack-knife repeated replication method
implemented in a SAS macro [17].
The 12 month prevalence and severity were estimated by
calculating means for dichotomous variables. Standard
errors were obtained as above to adjust for the effects of
weighting on the precision of estimates. Sociodemo-
graphic correlates were examined by transforming the pre-
dicted probabilities of class membership from the latent
class analysis method into logits, the natural logarithm of
the odds pic/(1-pic), where pic  is the probability that
respondent i is in class c, that were then used as dependent
Table 3: Prevalence of severity# of 12 month DSM IV disorders
Serious** Moderate** Mild**
%s e %s e % s e
Anxiety disorders
Panic disorder* 0.0 0.0 0.0 0.0 100.0 0.0
Generalized Anxiety Disorder* 82.5 17.7 17.5 17.7 0.0 0.0
Specific phobia* 23.4 7.4 34.6 8.8 41.9 10.6
Social phobia* 43.5 15.8 56.5 5.8 0.0 0.0
Agoraphobia without panic* 76.1 18.1 16.0 13.4 7.9 7.4
PTSD** 31.3 24.2 21.6 18.0 47.1 29.1
SAD/ASA** 22.2 21.7 77.8 21.7 0.0 0.0
Any Anxiety disorder* 30.2 10.8 8.8 9.7 31.0 9.1
Mood disorders
Major Depressive disorder* 45.6 14.9 43.7 12.8 10.7 5.4
Dysthymia* 27.6 23.1 72.4 23.1 0.0 0.0
Bipolar I/II/Sub threshold* 57.3 14.8 24.1 11.9 18.6 12.7
Any Mood disorder* 47.5 11.2 41.0 9.7 11.5 4.8
Impulse Control disorders
Conduct disorder** 0.0 0.0 0.0 0.0 100.0 0.0
Attention Deficit Hyperactivity disorder** 52.2 31.2 15.5 16.2 32.3 28.1
Intermittent Explosive disorder* 9.9 6.5 47.8 17.4 42.3 16.7
Any Impulse control disorder** 11.0 6.3 44.0 16.3 45.0 15.6
Any Disorder** 22.4 6.8 44.9 7.5 32.7 6.9
Total sample** 2.3 0.8 4.7 1.0 3.4 0.8
# Severity for 12 month period is calculated using part 2 weights.
* Part 1 sample.
** Part 2 sample.Child and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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variables in linear regression equations for effects of soci-
odemographic variables on the odds of class membership.
Regression coefficients were exponentiated and inter-
preted as odds ratios with design-based 95% confidence
intervals [17]. Multivariate significance was evaluated as
mentioned above. The severity was calculated using Part 2
weights and as a dichotomous variable: 1 = severe or mod-
erate, 0 = mild. All significance tests were evaluated at 0.05
with two sided tests.
Results
Overview
The unweighted nationally representative P1 sample
(Table 1) consisted of 850 (50.5%) females and 832
(49.5%) males while the P2 sample had 269 females
(53.1%) and 238 males (47.0%) participants between 14
and 23 years respectively. The sample and population dis-
tributions revealed minor differences which were cor-
rected by post-stratification weighting. The table 1 looks
at the distribution of post-stratification variables both
unweighted, weighted and in the sampling frame of sec-
ondary school Omani students. The sex distribution of the
part 1 (P1) sample is within 2% of the national distribu-
tion. The same is noted for the Grade 2 Art and Grade 3
Science. Region-wise this discrepancy is a maximum of up
to 3%. The sex distribution for the part 2 (P2) sample, the
distribution for the Grade2 Science and North Batinah
region is nearly similar to that of the frame while discrep-
ancy ranging from 1 to 6% is noted in other categories.
Overall the random sub-sample fairly matches the
national distribution and can be considered as a repre-
sentative sample. The 14-16 years age group formed
30.38% (n = 511), 17-18 years age group 52.91% (n =
890) and 19-23 was 16.70% (n = 281). Amongst the
Omani adolescents and youths surveyed (Table 5), 13.9%
had one DSM IV diagnostic label, 4.5% had two or more
diagnostic labels while 1.6% qualified for three or more
diagnostic categories.
Lifetime prevalence estimates (Table 2)
Broadly, the prevalence of AMD was 4.3%, AAD 9.0% and
AICD was 3.5%. The prevalence of MDD was 3.0% while
bipolar mood disorder (BMD) was only 1%. Only 0.4%
suffered from Dysthymia. In the anxiety disorders group,
the prevalence of specific phobia was 5.8%, social phobia
1.6% and post traumatic stress disorder (PTSD) 0.5%.
Panic disorder and GAD were the least prevalent. SAD
(ASA) had an overall prevalence of 3% while Agoraphobia
without panic was 1.5%. In the impulse control disorder
category, IED showed 2% prevalence. The disorders hav-
ing childhood onset i.e. Attention Deficit Hyperactivity
Disorder (ADHD) and Conduct Disorder were only 0.2%
each.
Any mood disorder was 70% less in the younger (14-16)
age group, showed linear increase in prevalence across
increasing age groups and was statistically significant (p =
0.035). SAD (ASA) in the 17-18 age group (5.3%) was sig-
nificant (p = 0.027) in comparison to the lower and higher
age groups. Agoraphobia without panic was least in the
Table 4: Age at selected percentiles on the standardized age of onset distributions of disorders
Diagnosis group Disorder AOO*
Percentile 25
AOO Percentile 50 AOO Percentile 75
Anxiety Specific phobia 7 13 22
Any Anxiety 8 18 22
Mood MDD with hierarchy 16 18 19
Any mood disorder 16 19 20
Impulse control IED with hierarchy 13 18 20
All diagnosis Any diagnosis 11 18 22
*Age of Onset.
Table 5: Lifetime prevalence of having any diagnostic label
Age group
Diagnostic label/DSM IV 
Disorder
Total 14-16 years 17-18 years 19-23 years
N % SE % SE % SE % SE ChiSq df P
Any Diagnostic label** 126 13.9 1.7 13.4 3.3 14.5 2.4 12.6 3.2 0.2 2 0.892
2+ Diagnosis** 52 4.5 0.9 3.1 0.9 5.0 1.5 5.0 2.2 1.4 2 0.501
3+ Diagnosis** 16 1.6 0.8 0.5 0.3 2.4 1.4 0.9 0.5 2.2 2 0.339
** Part 2 sample.Child and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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19-23 age group (0.3%) and was statistically significant (p
= 0.01) across age group distribution.
12-month estimates (Table 2)
The estimates over the previous 12 month period when
compared with the lifetime prevalence, showed a lower
prevalence of 25% to 40% for MDD, specific phobia,
social phobia, AAD and AMD while there was an 80%
lower prevalence for ASA. The odds of being diagnosed as
having a DSM IV psychiatric disorder over the previous 12
months using part 2 weights after stratification by sex and
age group were not found to be significant. But when 12-
month DSM IV disorder groups were considered (Table
6), the mood disorders were 70% lower in the 14-16 age
groups (OR 0.3, 95% CI 0.1-1.0, chi square 7.0) in com-
parison to the other age groups.
Severity of illness for 12 month disorders (Table 3)
The category wise prevalence of severity of illness in the
total sample, without considering the standard errors was
2.3% serious, 4.7% moderate and 3.4% mild. In the anx-
iety disorder group approximately 82% of GAD and 76%
of Agoraphobia without panic were classified as serious,
while 78% of ASA fulfilled the moderate criteria. Around
58% of those with specific phobia and 100% of those
with social phobia had severity which was between mod-
erate and serious. All the respondents diagnosed with
panic disorder were categorized as mild. Amongst the
depression group, about 45% of those with MDD were
equally divided between serious and moderate severity
while 57% of the Bipolar I/II/Sub thresholds were classi-
fied as serious, while the majority of those with Dys-
thymia were classified as moderate (72%). All those with
conduct disorder were categorized as mild but 45% of IED
were classified as moderate and mild respectively and
55% of those with ADHD fulfilled the serious criteria. The
severity of illness was 80% less in females as compared to
males (OR 0.2, 95% CI 0.0-0.8, Chi square 4.9).
Age of onset for lifetime estimates (Table 4)
The specific phobias had an earlier median age of onset at
13 years while the onset age was 18-19 years for other dis-
orders. The mood disorders group showed a narrow age
range of onset risk, the interquartile range (IQR) being 16
to 19/20 years of age. The IQR for the anxiety group was
between 7-8 years and 22 years suggestive of an early age
of onset distribution. The median age of onset for all the
diagnoses considered together was 18 years (IQR 11-22).
Gender as a predictor of lifetime risk (Table 7)
Female gender has been found to be a strong predictor of
lifetime risk of MDD (OR 3.3, 95% CI 1.7-6.3, p = 0.000);
AMD (OR 2.5, 95% CI 1.4-4.3, p = 0.002) and specific
phobia (OR 1.5, 95% CI 1.0-2.4, p = 0.047).
Discussion
The World Mental Health Survey Initiative 2000 con-
ducted CIDI surveys between 2001 and 2005 in different
countries of which 17 study findings have been published
[22]. The study cohorts belonged to the age groups of 18
years and above. Lebanon and Israel were the only two
countries which reported from the Middle East. The
present study in the same time period, to our knowledge,
was the first CIDI survey among the adolescents and
youths between 14 and 23 years in this region. This cohort
closely resembles the New Zealand study conducted dur-
ing a similar time period which included those aged 16+
years though only the 18+ age group was analyzed.
The use of WHO-CIDI is justified as it is the only available
instrument based on extensive cross-national field trials.
The adult CIDI surveys have consistently shown that anx-
iety disorders have a median age of onset in the early to
late teens, while mood disorders have a median age of
onset in the early to mid twenties [2]. The 18+ age group
respondents in this study contributed only 16.70% to the
overall sample but still the results of adult studies have
been used for discussion in the present paper, in spite of
inherent limitations, so as to help corroborate the find-
ings in the preceding statement and also facilitate interna-
tional comparisons based on one standardized
instrument. Hence the findings of other studies which
have used different instruments on the respondent sam-
Table 6: Correlates of 12 month DSM IV disorder groups
Mood Anxiety Impulse control
OR 95%CI OR 95%CI OR 95%CI
Gender
Male 1.0 ... 1.0 ... 1.0 ...
Female 1.4 0.5-3.8 2.0 0.7-5.9 2.3 0.4-12.6
Chi square 0.4 1.6 1.0
Age
14-16 0.3 0.1-1.0 1.1 0.4-3.3 1.0 0.2-5.2
17-18 1.1 0.4-3.0 2.2 0.7-6.7 0.3 0.1-1.3
19-23 1.0 1.0 1.0
Chi square 7.0 3.6 3.7Child and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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ple similar to ours have been avoided in discussion as far
as possible.
The response rate in the present study was 91.61%. In the
literature, it ranged between a minimum 45.9% in France
and a maximum 87.7% in Columbia while the respective
response rates were 70% for Lebanon, Israel 72.6%, and
New Zealand 73.3% [22]. The higher compliance in the
present study may be due to the fact that the study was
conducted with the constraints and advantages of a school
setting. It is possible that the response rate from commu-
nity-based surveys rather than school-based ones would
strongly hinge on the adults' choice to either participate in
the study or not. Therefore, it appears that a community
survey tends to have a lower response rate.
The initial finding of a prevalence of 17% of depressive
symptoms based on self reported CDI [11] in the source
sample translated during the same time period to mark-
edly lower estimates of lifetime prevalence of MDD and
BMD. Studies in adolescents and youth using different
research methodologies have reported variable estimates
of depressive symptoms from about 9% to between 25%
and 40% [23,24]. The present study suggests that one
need not be alarmed by results based on depressive symp-
toms only but it endorses the adult studies findings that
mental disorders do begin earlier in life. A vast majority of
adults with serious mental disorders experience a combi-
nation of panic, generalized anxiety, depression, phobia
and substance abuse which differ substantially in their
ages of onset. Anxiety, oppositional-defiant and atten-
tion-deficit problems typically have earlier ages of onset.
It is hypothesized that the cumulative effect of these dis-
orders could be of causal significance and hence measures
need be taken to reduce the prevalence of serious mental
disorders in adolescents and youths [25].
In the prevalence estimates over previous 12 month
period, lower prevalence is noted for MDD, specific pho-
bia, ASA and any anxiety and any mood category as com-
pared to the lifetime prevalence suggestive of an earlier
onset. The decrease could perhaps be attributed to natural
causes or available treatment. The linear increase seen in
the prevalence of any mood disorders in the lifetime esti-
mates confirms the earlier findings that mood disorders
have a later age of onset [26].
The age of onset distributions for lifetime estimates over-
lap with the findings of adult studies from other countries
[22] necessitating the targeting of this population in
Oman for further investigation and intervention if neces-
sary. The results corroborate with other studies which
show that impulse control disorders have the earliest age
of onset distributions, an early median age of onset and a
narrow age of onset risk between 13 and 21 years. The esti-
mation was not done for the other subgroups, as the
respondents were fewer than 30 in the study sample. The
median age of onset for specific phobia was 13 years and
well within the 7-14 years range reported. But the IQR of
7-22 years in this study varied from the narrow IQR of 8-
11 years in other studies. This could be due to a relatively
smaller sample size in a limited age range. The other anx-
iety subgroups had a later median age of onset (median
25-50 years, IQR 31-41) in adult surveys. This study
showed a similar trend, with a later median age of onset
at 18 years (IQR 8-22 years) for the any anxiety category
when compared to specific phobias. The difference
between the impulse control group and phobias in com-
parison with the other anxiety disorder groups can be
attributed to wider cross-national variations in the latter.
This must be interpreted with caution due to the method-
ological considerations [22]. The discrepancy in IQR for
specific phobia in this study compared to others could be
due to the same reason. For mood disorders, the reported
prevalence is consistently low until the early teens, at
which time a roughly linear increase begins that continues
through the late middle age, with a more gradual increase
thereafter and this study results are on similar lines.
Studies seem to indicate that the odds ratios for anxiety
and mood disorders are higher in the recent cohorts com-
pared to the older cohorts [22]. These studies compared
each cohort of approximately 15 years and consisted of 4
cohorts ranging from 18 years to 65+. This study being
Table 7: Gender as the predictor of lifetime risk
Female
OR 95% CI Chi Sq
(df = 1)
P
Specific phobia 1.5 1.0-2.4 3.9 0.047
Anxiety disorder 1.2 0.6-2.4 0.3 0.602
Major Depressive Disorder 3.3 1.7-6.3 12.8 0.000
Any Mood disorder 2.5 1.4-4.3 9.5 0.002
Intermittent Explosive disorder 2.5 1.0-6.1 3.7 0.055
Any disorder 1.6 0.9-2.9 3.0 0.085Child and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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restricted to three narrow cohorts of 14-16, 17-18 and 19-
23 years perhaps did not exhibit the above trend.
The female gender proved to be a strong predictor of life-
time risk of MDD, AMD and specific phobia. A differential
willingness hypothesis has been proposed as a plausible
explanation of the observed finding that women report
higher rates of anxiety and depression than males who
tend to under report, thus leading to biased estimates
[27]. Alternatively, there may be gender-specific factors
that contribute to such a discrepancy, but it is beyond the
scope of discussion in this paper.
This study demonstrated a significant increase in lifetime
prevalence in agoraphobia without panic and SAD/ASA in
the 17-18 year age group compared to the lower and
higher age groups. Cross-nationally these disorders show
an inverted U-shaped trend and tend to decrease as age
increases [2]. The estimates of mild and moderate severity
in the anxiety spectrum in this study appear to contradict
the above findings due to this study being restricted to
three narrow cohorts in a restrictive age range. Also, as the
anxiety spectrum illnesses tend to be characterized by
somatic distress, it is possible that cultural factors may
have played a part in the present trend. Further explora-
tion into this phenomenon is therefore warranted. The
rates for lifetime prevalence in the three classes of having
any disorders are comparable to other cross national stud-
ies [22] which suggest the IQR of 9.9-16.7% for any anxi-
ety disorders and the IQR of 3.3-21.4% for any mood
disorders. The younger cohort in our study could account
for lower bound estimates of prevalence rates. The
Impulse control disorders are comparably least prevalent
(IQR 3.1-5.7%) across countries and our sample showed
a similar trend for lifetime prevalence. The narrow age
groups of the respondents in our study accounts for a lim-
ited age range of onset risk in the mood disorders group.
The WMH measures of severity were applied only to 12
month cases as there is at present no way to estimate the
severity of lifetime cases. The prevalence of severity is
quite similar to the available findings in other countries
where the majority of cases between 33% and 90% (IQR
40-53%) were rated mild [28], but even mild cases could
be impairing and evolve into more serious disorders over
time [29]. The odds of severity were 80% less in females
which can be attributed to their willingness to discuss per-
sonal problems which had a cathartic effect and hence
reduced the severity of the problem. It has been noted that
individuals who air their emotional experiences are likely
to have positive health outcomes [30]. The no difference
in the odds of severity across age groups was because of
the narrow age range in this study.
A recent review of the magnitude of mental disorders in
children and adolescents from recent community surveys
across the world demonstrated that though there is sub-
stantial variation in the results depending upon the meth-
odological characteristics of the studies, the findings
demonstrate that approximately one fourth of youths
experienced a mental disorder during the past year, and
about one third across their lifetimes. Anxiety disorders
are the most frequent conditions in children, followed by
behavior disorders and mood disorders [31]. A similar
trend was noted in this study. Belfer, reporting the find-
ings of different researchers', states that children with
depression, ADHD and conduct disorder have higher
rates of health care utilization, impose costs on society in
terms of education, and are a burden on the criminal jus-
tice system and on social services [8]. In 2002, only 7% of
the countries worldwide (14 out of 191) had a clearly
articulated specific child and adolescent mental health
policy [32]. Ironically, the countries with the highest pro-
portion of children and adolescents in their populations
are those countries that are most likely to lag behind in
child and adolescent mental health policy [33].
Suggestions
The situation in Oman, in spite of findings with lower
bound estimates, does present a cause for concern, con-
sidering the majority of the population is still in adoles-
cence and youth. If the present findings can withstand
further scrutiny, Oman needs to institute an informed
agenda for the welfare of its adolescents and youth vis-à-
vis mental health policy. A longitudinal study in Oman to
assess adult outcomes of adolescent psychological prob-
lems will be essential if not paramount to set in motion
evidence-based policy and services for people with mental
illness. Similarly there is an urgent need to estimate the
burden of mental problems amongst adults in Oman
since strong evidence has emerged from adult studies that
mental disorders have much earlier ages of onset than
other chronic diseases. An awareness of mental problems
amongst parents, teachers and students by health educa-
tors and the media could assist in addressing the stigma of
mental illness and limit the tendency to under-report
mental distress or not to report it at all. This could ensure
better participation with proper understanding in such
surveys to yield reliable estimates.
Limitations
The present findings are discussed with some of the possi-
ble limitations that are often an integral part of such stud-
ies which have a cross-sectional design. The ecological
validity would have been heightened if the information
elicited were corroborated across a range of situations
including opinions from parents and teachers. Similarly,
it is possible that the present survey may have omitted
those who had dropped out from school as a result of
mental ailments and also those who were non-school
going for other reasons. The lower bound estimates of
mental illness among secondary school respondents inChild and Adolescent Psychiatry and Mental Health 2009, 3:29 http://www.capmh.com/content/3/1/29
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Oman merits some speculation. Mental disorders carry
stigma worldwide including in Oman [34] and hence con-
cerns have been raised about under-reporting as a serious
problem in any epidemiological survey [35]. The esti-
mated lifetime prevalence of having any disorder varied
widely from 47.4% in United States to 12% in Nigeria,
with lower estimates in developing countries such as Peo-
ples' Republic of China. Other countries which reported
lifetime prevalence estimates are Lebanon 25.8%, Israel
17.6% and New Zealand 39.3% [22]. Around 14% of our
sample has at least one lifetime diagnostic label which is
below the 25th percentile observed across other countries
which had IQR between 18.1-36.1%. The cultural teach-
ings that tend to perceive psychiatric distress as physical
illness may have contributed to reporting bias. The varia-
ble estimates could also be due to interviewer errors as
noted in other surveys because the interviewers rushed
through the interviews as they were paid per interview
rather than hourly [22]. This could hold true for our study
even though the payment was made per month. However
in this present study it was difficult to ascertain whether
the students' unwillingness to report symptoms could
have been affected due to the presence of the school
health doctor who conducted the interview. Along with
this factor, the questionnaire, being too detailed and time
consuming, could have caused fatigue in the respondents
of this age group, perhaps resulting in negative replies. It
has been reported that the prevalence of emotional prob-
lems reported in epidemiological surveys should be con-
sidered lower bound estimates rather than accurate
reflections of the true prevalence in the population [36].
The other possibility that these young respondents may
have given some affirmative replies without really under-
standing the content of the questions or without knowl-
edge of its implications just to satisfy the interviewer in
the form of a person of authority cannot be denied. This
and the interviewer errors mentioned above could also
result in inflated estimates.
Much of the emotional turbulence especially during the
adolescence period is known to resolve in adulthood [2].
Costello et al [37] recommend that caution should be
exercised about the clinical significance of less serious
symptoms unless longitudinal studies prove that these are
associated with a risk of future clinically significant disor-
ders. On the other hand, there is evidence to suggest that
single disorders often progress to complex co-morbid dis-
orders that are impervious to treatment and more likely to
recur than less complex conditions [25]. Therefore, our
subjects need to be re-assessed at a later period for a mean-
ingful understanding of the impact of the present labe-
ling.
Conclusion
The younger cohort in our study could account for lower
bound estimates of prevalence rates in comparison to
adult findings. The implications of the present findings
are not clear cut, however this study endorses the adult
CIDI studies findings that mental disorders do begin ear-
lier in life. The relatively lower prevalence of depressive
disorders cautions against being alarmed by results based
on studies of depressive symptoms on the same sample in
the same time period.
The female gender proved to be a strong predictor of life-
time risk of MDD, AMD and specific phobia. The odds of
severity of illness were significantly less in females, per-
haps due to their willingness to discuss personal problems
which has a cathartic effect. Under-reporting by males or
some other gender-specific factors may contribute to such
a discrepancy and needs to be investigated.
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